FDA to limit access to diabetes drug Avandia

Concerns about an increased cardiovascular risk associated with the drug prompt the agency to require new consent forms for patients and new standards for doctors when writing prescriptions.The Food and Drug Administration said Thursday that it will sharply limit access to the anti- diabetes drug Avandia because of concerns about an increased cardiovascular risk associated with the drug.

Read the whole article on LA Times - Science

More from LA Times - Science